Learn More
Medchemexpress LLC Pro8-oxytocin (TFA) | 24327-19-3 | 99.7% | 1 MG

Supplier: Medchemexpress LLC HYP4990A1MG
Pro8-Oxytocin TFA is a modified oxytocin (OXT) ligand. It produces more potent and efficacious responses at primate OXTR and stronger behavioral effects compared to the consensus mammalian OXT ligand. It also elicits a less efficacious response than vasopressin at human AVPR1a and a higher efficacious response than vasopressin at marmoset AVPR1a.
- Modified oxytocin (OXT) ligand
- Produces more potent and efficacious responses at primate OXTR
- Exhibits stronger behavioral effects than the consensus mammalian OXT ligand
- Elicits a less efficacious response than vasopressin at human AVPR1a
- Elicits a higher efficacious response than vasopressin at marmoset AVPR1a
- Activates Ca2+ mobilization in AVPR1a in CHO cells
- Binds with higher affinity at primate OXTR
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.